Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer (Q39870536)
Jump to navigation
Jump to search
scientific article published on 20 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer |
scientific article published on 20 March 2009 |
Statements
1 reference
Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer (English)
1 reference
De-Yuan Fu
1 reference
Zhi-Min Wang
1 reference
Li-Chen
1 reference
Bei-Lan Wang
1 reference
Zhen-Zhou Shen
1 reference
Wei Huang
1 reference
Zhi-Ming Shao
1 reference
20 March 2009
1 reference
1 reference
119
1 reference
3
1 reference
601-612
1 reference
Identifiers
1 reference
1 reference